Ken Griffin Organovo Holdings, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 16,200 shares of ONVO stock, worth $12,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,200Holding current value
$12,312% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ONVO
# of Institutions
36Shares Held
885KCall Options Held
16.2KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA354KShares$268,7450.0% of portfolio
-
Black Rock Inc. New York, NY142KShares$108,0780.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny97.8KShares$74,3180.0% of portfolio
-
Geode Capital Management, LLC Boston, MA74.9KShares$56,9310.0% of portfolio
-
Morgan Stanley New York, NY42.1KShares$32,0270.0% of portfolio
About ORGANOVO HOLDINGS, INC.
- Ticker ONVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,712,020
- Market Cap $6.62M
- Description
- Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...